Freenome, Inc. (FRNM)
NASDAQ: FRNM · Real-Time Price · USD
10.18
-0.29 (-2.77%)
At close: Nov 6, 2026, 4:00 PM EST
10.30
+0.12 (1.18%)
After-hours: Nov 6, 2026, 7:30 PM EST
Freenome Revenue
Freenome had revenue of $2.27M in the quarter ending June 30, 2026, with 477.16% growth. This brings the company's total for the last twelve months to $35.41M. In the year 2025, Freenome had annual revenue of $30.41M with 955.14% growth. That makes Freenome the 30,311th largest company in the world by revenue and 4,007th in the United States.
Revenue (ttm)
$35.41M
Revenue Growth
+955.14%
P/S Ratio
30.89
Revenue / Employee
$92,940
Employees
381
Market Cap
1.09B
Revenue by Geography
- United States 27.46M 90.3%
- International 2.95M 9.7%
Fiscal year ended Dec 31, 2025 See the full Freenome breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.41M | 27.53M | 955.14% |
| Dec 31, 2024 | 2.88M | 780.00K | 37.11% |
| Dec 31, 2023 | 2.10M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
FRNM News
- 19 days ago - Freenome rallies after launching lung cancer screening blood test - TheFly
- 19 days ago - Freenome Expands Personalized Cancer Detection Portfolio, Launching SimpleScreen™ Lung Test With FDA-Approved SimpleScreen CRC Option - GlobeNewsWire
- 24 days ago - Freenome to Report Third Quarter 2026 Financial Results on November 10, 2026 - GlobeNewsWire
- 4 weeks ago - Freenome to present new data on updated version of SimpleScreen CRC - TheFly
- 2 months ago - Elevance update guidelines cover Freenome CRC test, says Guggenheim - TheFly
- 2 months ago - Freenome initiated with a Buy at Guggenheim - TheFly
- 2 months ago - Freenome initiated with a Buy at Guggenheim - TheFly
- 2 months ago - Freenome files to sell 75.19M shares of common stock for holders - TheFly